Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 189-202, July 2007

Mobilization of human CD34+CD133+ and CD34+CD133 stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae—related to modulation of CXCR4 expression by an L-selectin ligand?

  • Gitte S. Jensen

      Affiliations

    • Holger NIS, 601 13 Avenue NE, Calgary, Alberta, Canada T2E 1C7
    • Corresponding Author InformationCorresponding author. Tel.: +1 403 277 4134.
  • ,
  • Aaron N. Hart

      Affiliations

    • NIS Labs, 1437 Esplanade, Klamath Falls, OR, USA
  • ,
  • Lue A.M. Zaske

      Affiliations

    • NIS Labs, 1437 Esplanade, Klamath Falls, OR, USA
  • ,
  • Christian Drapeau

      Affiliations

    • StemTech Health Sciences Inc., 1011 Calle Amanecer, San Clemente, CA, USA
  • ,
  • Niraj Gupta

      Affiliations

    • Cancer Treatment Center, Merle West Medical Center, 2610 Uhrmann Rd, Klamath Falls, OR, USA
  • ,
  • David J. Schaeffer

      Affiliations

    • Department of Veterinary Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, USA
  • ,
  • J. Alex Cruickshank

      Affiliations

    • NIS Labs, 1437 Esplanade, Klamath Falls, OR, USA

The coauthor C. Drapeau is Chief Science Officer for StemTech Health Sciences, which distributes the product StemEnhance, used for the in vivo part of this paper. No other authors have any commercial interest in the subject matter.

Abstract 

Objective

The goal of this study was to evaluate effects on human stem cells in vitro and in vivo of an extract from the edible cyanobacterium Aphanizomenon flos-aquae (AFA) enriched for a novel ligand for human CD62L (L-selectin).

Experimental approach

Ligands for CD62L provide a mechanism for stem cell mobilization in conjunction with down-regulation of the CXCR4 chemokine receptor for stromal derived factor 1. Affinity immunoprecipitation was used to identify a novel ligand for CD62L from a water extract from AFA. The effects of AFA water extract on CD62L binding and CXCR4 expression was tested in vitro using human bone marrow CD34+ cells and the two progenitor cell lines, KG1a and K562. A double-blind randomized crossover study involving 12 healthy subjects evaluated the effects of consumption on stem cell mobilization in vivo.

Results

An AFA extract rich in the CD62L ligand reduced the fucoidan-mediated externalization of the CXCR4 chemokine receptor on bone marrow CD34+ cells by 30% and the CD62L+ CD34+ cell line KG1A by 50% but did not alter the CXCR4 expression levels on the CD34 cell line K562. A transient, 18% increase in numbers of circulating CD34+ stem cells maximized 1 hour after consumption (P<.0003). When 3 noncompliant volunteers were removed from analysis, the increase in CD34+ cells was 25% (P<.0001).

Conclusion

AFA water extract contains a novel ligand for CD62L. It modulates CXCR4 expression on CD34+ bone marrow cells in vitro and triggers the mobilization of CD34+ CD133+ and CD34+ CD133 cells in vivo.

Abbreviations: AFA, Aphanizomenon flos-aquae, PBMC, Peripheral blood mononuclear cells, PMN, Polymorph-nucleated cells

Keywords: L-selectin, Ligand, Human, Adult stem cell, CD34, CD133, KG1a, K562, Bone marrow, Mobilization, Blue-green algae, Cyanobacteria, Aphanizomenon, In vivo, In vitro

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This project was supported by the Merle-West Center for Medical Research, a nonprofit research organization, Desert Lake Technologies, a harvester of Aphanizomenon flos-aquae, and NIS Labs, an independent natural products research laboratory.

PII: S1553-8389(07)00049-8

doi:10.1016/j.carrev.2007.03.004

Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 189-202, July 2007